TY - JOUR T1 - 019鈥� Autologous stem cell transplantation versus alemtuzumab or ocrelizumab in relapsing remitting multiple sclerosis (StarMS) JO - Journal of Neurology, Neurosurgery & Psychiatry UR - https://doi.org/10.1136/jnnp-2022-abn.58 PY - 2022/05/27 AU - Sharrack B AU - Snowden J AU - Muraro P ED - DO - DOI: 10.1136/jnnp-2022-abn.58 PB - BMJ VL - 93 IS - 6 SP - A19.2 EP - A19 Y2 - 2025/11/06 ER -